Manuel
Barreiro de Acosta
Instituto de Investigación Sanitaria La Fe
Valencia, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria La Fe (5)
2017
-
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation
Digestive Diseases and Sciences, Vol. 62, Núm. 2, pp. 481-490
2016
-
Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's disease
Gastroenterologia y Hepatologia, Vol. 39, Núm. 4, pp. 255-260
2015
-
Response to infliximab in Crohn's disease: Genetic analysis supporting expression profile
Mediators of Inflammation, Vol. 2015
2014
-
Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab
Human Immunology, Vol. 75, Núm. 1, pp. 71-75
2013
-
Safety of thiopurine therapy in inflammatory bowel disease: Long-term follow-up study of 3931 patients
Inflammatory Bowel Diseases, Vol. 19, Núm. 7, pp. 1404-1410